# OpenAI, PerturbAI and Scripps Research use GPT‑Rosalind agents to analyze mouse brain data

Digest AI · Agents & Tools · published 2026-10-21T04:50:00Z · updated 2026-10-21T07:14:00Z

Canonical: https://digestai.news/story/openai-perturbai-and-scripps-research-use-gptrosalind-agents-to-analyz

## Summary

OpenAI, PerturbAI and Scripps Research teamed up to run thousands of AI agents powered by GPT‑Rosalind on a whole‑brain CRISPR atlas that contains data from millions of mouse brain cells. The distributed agents examined each gene disruption, linked cellular responses to scientific literature, and compiled their findings into a reasoning atlas in just 32 minutes.

The study reports that the parallel agents cited more than 700 literature references, while a single agent run on the same workload referenced only 11 papers. Human experts judged the distributed‑agent interpretations as more novel and valuable than the single‑agent output. The reasoning atlas uncovered unexpected biological connections, such as a possible link between cholesterol regulation and neurodegeneration and distinct effects of the disease‑linked genes Tsc1 and Tsc2 in cerebellar neurons.

The atlas is now publicly available, allowing other researchers to explore gene‑cell relationships, compare literature links, and prioritize follow‑up experiments. By scaling the analysis of massive cell atlases, the approach demonstrates how AI can accelerate hypothesis generation for diseases like Alzheimer’s, Parkinson’s, and other neurodegenerative conditions.

## Key points

- Thousands of GPT‑Rosalind agents analyzed a whole‑brain CRISPR atlas of millions of mouse cells in 32 minutes.
- Distributed agents cited over 700 literature references, while a single agent at the same workload cited only 11.
- The reasoning atlas highlighted a potential cholesterol‑neurodegeneration link and distinct Tsc1 vs Tsc2 effects in cerebellar neurons.

## Why it matters

Scaling biological reasoning with thousands of AI agents lets researchers extract insights from massive cell atlases quickly, accelerating hypothesis generation for neurodegenerative disease research.

## Sources

1. [Using thousands of AI agents to uncover new leads in biological data](https://openai.com/index/scaling-ai-research-for-complex-biological-data) (OpenAI, 2026-10-21, primary source)
2. [OpenAI uses nearly 2,000 AI agents to analyze brain CRISPR data in 32 minutes](https://cryptobriefing.com/openai-ai-agents-brain-crispr-atlas) (cryptobriefing.com, 2026-10-21)

## Cite

Digest AI, "OpenAI, PerturbAI and Scripps Research use GPT‑Rosalind agents to analyze mouse brain data", 21 October 2026, https://digestai.news/story/openai-perturbai-and-scripps-research-use-gptrosalind-agents-to-analyz

---

Written by Digest AI's editorial model from the linked sources; the sources are the record. Headlines, digests and key points are written by Digest AI and may be quoted with a link to the story page. Linked articles belong to their publishers. Terms: https://digestai.news/terms#reuse
JSON: https://digestai.news/story/openai-perturbai-and-scripps-research-use-gptrosalind-agents-to-analyz.json